ArticleThe Lancet regional health. Europe2025
Incidence rate of infective endocarditis by socioeconomic position: a Danish nationwide cohort study (2000-2022).
Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Infective Endocarditis in Ireland: A Nationwide Analysis.Journal of clinical medicine · 2026Article
- Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.Pathogens (Basel, Switzerland) · 2026Review
- Long-term outcomes of mitral valve surgery in infective endocarditis: a single-centre UK experience.Open heart · 2026Article
- Socioeconomic disparities in long-term mortality after infective endocarditis in Denmark: a nationwide cohort study.The Lancet regional health. Europe · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: People with lower socioeconomic positions have a higher risk of cardiac and infectious diseases than those with higher socioeconomic positions. However, how the increasing incidence of infective endocarditis among different socioeconomic groups has played out remains unclear. We therefore aimed to investigate nationwide temporal trends in infective endocarditis incidence rate by socioeconomic position in Denmark. Methods: Using nationwide Danish registries, we investigated infective endocarditis incidence rate (2000-2022). As socioeconomic position indicator, we used affluence level (accounting for household-level income and wealth), dividing the population into low, medium, and high affluence. Average annual percentage changes were computed to evaluate temporal trends. Slope index and relative index of inequality were calculated to obtain inequality gradients. Findings: Per 100,000 person-years, the incidence rate increased from 8.7 in 2000 to 21.2 in 2022 among low; from 7.4 to 14.3 among medium; and from 6.2 to 13.1 among high affluence people. The average annual percentage change was 4.3% among low, 3.5% among medium, and 3.7% among high affluence people. The slope index of inequality increased from 3.8 additional cases per 100,000 person years (95% CI: 0.4-7.3) in 2000 to 12.3 (95% CI: 7.4-17.1) in 2022. The relative index of inequality increased from 1.68 (95% CI: 0.90-2.44) to 2.13 (95% CI: 1.49-2.78). Interpretation: The infective endocarditis incidence rates increased in all affluence levels, with highest rates consistently found in the lowest affluence group, indicating that people with lower socioeconomic positions faced a disproportionately higher risk of infective endocarditis. These findings highlight the need to consider socioeconomic factors when addressing modifiable determinants that may curb the rise in infective endocarditis incidence. Funding: Independent Research Fund Denmark (grant no. 3101-00102B) and Center for Population Medicine, Department of Clinical Epidemiology, Aarhus University.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.